Express News | Top 10 Trending Stocks On WallStreetBets As Of July 3 2024 (Via Swaggy Stocks)
Express News | Tiziana Shares Are Trading Higher After the Company Received $3.4 Million in Non-dilutive Funding
Express News | Tiziana Life Sciences Receives $3.4M Non-Dilutive Funding; Provides Corporate Update On Breakthrough Therapies For Neurodegenerative Diseases
Express News | Tiziana Receives $3.4 Million in Non-Dilutive Funding
Press Release: Tiziana Receives $3.4 Million in Non-Dilutive Funding
Tiziana Receives $3.4 Million in Non-Dilutive Funding NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company deve
Express News | Tiziana Life Sciences Says It Will Dose First Patient With Moderate Alzheimer's Disease With Foralumab
Express News | Tiziana Life Sciences: FDA Has Allowed Intranasal Foralumab to Be Used Under Expanded Access Ind in First Patient With Moderate Alzheimer S Disease
Tiziana Life Sciences to Dose First Patient With Moderate Alzheimer's Disease With Foralumab
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug
Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; Nvidia to Decline, Micron Technology to Open Higher
The most-talked-about stocks in the Reddit subforum Wallstreetbets were mixed hours before Monday's opening bell. Nvidia (NVDA) fell by 2.4% in premarket hours, declining further after closing Friday
12 Health Care Stocks Moving In Monday's After-Market Session
GainersASLAN Pharma (NASDAQ:ASLN) shares moved upwards by 11.9% to $0.4 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million. Biora Therapeutics (NASDA
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
Tiziana Multiple Sclerosis Asset Foralumab Fast Track Application Accepted
Express News | Tiziana Life Sciences Receives FDA Acceptance For Fast Track Designation Submission Of Intranasal Foralumab For Treating Non-Active Secondary-Progressive Multiple Sclerosis (Na-SPMS)
Express News | FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
Tiziana Life Sciences Seeks FDA Fast Track Designation for Foralumab in MS Treatment | NASDAQ:TLSA
12 Health Care Stocks Moving In Friday's After-Market Session
GainersAnitra (AMEX:AZTR) stock rose 17.0% to $0.17 during Friday's after-market session. The company's market cap stands at $5.0 million. Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 12
Tiziana Life Sciences Reports Six-Month Qualitative Results For All 10 Non-Active Secondary Progressive Multiple Sclerosis Patients Enrolled In Intermediate-Size Patient Population Expanded Access Program
Qualitative improvements in PET imaging seen in 80% of non-active Secondary Progressive Multiple Sclerosis (na-SPMS) Expanded Access patients receiving intranasal foralumab for at least 6-months.FDA A
Express News | Tiziana Life Sciences Ltd: Applied for FDA Orphan Drug Designation of Foralumab for NA-Spms
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
Qualitative improvements in PET imaging seen in 80% of non-active Secondary Progressive Multiple Sclerosis (na-SPMS) Expanded Access patients receiving intranasal foralumab for at least 6-months.FDA Allowance for an
Tiziana Life Sciences Reports Qualitative Improvement in MS Patients Treated With Lead Asset | NASDAQ:TLSA